HCA Healthcare, Inc. (NYSE:HCA) Stock Holdings Increased by CX Institutional

CX Institutional lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 32.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,726 shares of the company's stock after acquiring an additional 5,019 shares during the period. CX Institutional's holdings in HCA Healthcare were worth $7,162,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in HCA. Atwood & Palmer Inc. acquired a new stake in shares of HCA Healthcare in the first quarter worth $28,000. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at $31,000. Tidemark LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at $36,000. Legacy Investment Solutions LLC grew its holdings in HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after purchasing an additional 95 shares in the last quarter. Finally, Physician Wealth Advisors Inc. acquired a new stake in HCA Healthcare during the 4th quarter valued at $64,000. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Stock Performance

NYSE:HCA traded down $0.91 during mid-day trading on Friday, hitting $370.76. The stock had a trading volume of 872,296 shares, compared to its average volume of 1,452,711. The stock has a market capitalization of $89.20 billion, a price-to-earnings ratio of 16.88, a P/E/G ratio of 1.10 and a beta of 1.49. The company has a 50 day simple moving average of $358.43 and a 200-day simple moving average of $333.12. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. HCA Healthcare's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the firm posted $5.36 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.78%. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on HCA shares. Guggenheim started coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating for the company. Royal Bank of Canada decreased their price objective on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, Robert W. Baird reissued a "neutral" rating and set a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $392.47.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.